Showing results (1411-1420 of 6,754) with videos related to

Sort By:
Pageof 676
European Journal of Endocrinology|March 8, 2018
Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomasEmilia Sbardella, Marianna Minnetti, Denise D'Aluisio, et al.
European Journal of Endocrinology|March 4, 2018
Developmental milestones at one year for the offspring of mothers with congenital hypothyroidism: a population-based studyJuliane Léger, Anne Forhan, Sophie Dos Santos, et al.
European Journal of Endocrinology|March 4, 2018
Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trialGudmundur Johannsson, Ulla Feldt-Rasmussen, Ida Holme Håkonsson, et al.
European Journal of Endocrinology|May 12, 2012
MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990GlyMarcello Filopanti, Uberta Verga, Federica Ermetici, et al.
European Journal of Endocrinology|May 24, 2012
Expression profile of apoptosis-related genes in childhood adrenocortical tumors: low level of expression of BCL2 and TNF genes suggests a poor prognosisCecília Fernandes Lorea, Daniel Antunes Moreno, Kleiton Silva Borges, et al.
European Journal of Endocrinology|April 19, 2012
Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatmentAtanaska Elenkova, Rabhat Shabani, Krassimir Kalinov, et al.
European Journal of Endocrinology|July 26, 2015
Lowered cutoff of lymph node fine-needle aspiration thyroglobulin in thyroid cancer patients with serum anti-thyroglobulin antibodyKwanhoon Jo, Min-Hee Kim, Yejee Lim, et al.
European Journal of Endocrinology|August 19, 2015
Subclinical hypercortisolism: a state, a syndrome, or a disease?Guido Di Dalmazi, Renato Pasquali, Felix Beuschlein, et al.
European Journal of Endocrinology|August 13, 2015
The modulation of corticosteroid metabolism by hydrocortisone therapy in patients with hypopituitarism increases tissue glucocorticoid exposureMark Sherlock, Lucy Ann Behan, Mark J Hannon, et al.
European Journal of Endocrinology|August 13, 2015
The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defectsS H Donze, C R Meijer, S G Kant, et al.
Pageof 676